국내 200병상이상 의료기관의 다약제 내성균 감염관리 실태조사

다국어 초록 (Multilingual Abstract)

This study was performed to investigate the current status of isolation precautions of multidrug resistant organisms(MDROs) in general hospitals with more than 200bed. The questionnaires were mailed from 3rd, April 2013 to 30th, April 2013. Methicillin resistant Staphylococcus aureus:(MRSA), vancomycin resistant Staphylococcus aureus:(VRSA), vancomycin resistant Enterococcus(VRE), multidrug-resistant Acinetobacter baumannii, carbapenem-resistant Enterobacteriaceae multidrug-resistant Pseudomonas aeruginosa were enrolled. MRSA(100.0%) and VRE(98.7%) were isolated respectively. VRE(97.3%) and MRSA(64.0%) were regulated strictly respectively. VRE(91.5%) and VRSA(50.7%) were isolated in a single room respectively. Hospital being located in Seoul(p<0.001), and beds(≥600)(p=0.008) were different significantly. The isolation space limitation(71.1%) was the highest difficulty. The development of refunding the costs of the extra supplies and other hygienic materials for infection control was discovered as the most urgent strategy.

목차 (Table of Contents)

• Ⅰ. 서론
• Ⅱ. 연구방법
• 1. 연구도구
• 2. 연구기간
• 3. 자료분석
• Ⅲ. 연구결과
• 1. 일반적 특성
• 2. 다제내성균 감염관리 실태
• 3. 다제내성균 감염관리 실태에 영향을 미치는 요인
• 4. 다제내성균 감염관리 문제와 개선의견
• Ⅳ. 고찰 및 결론
• 1. 고찰
• 2. 결론
• REFERENCES

참고문헌 (Reference)

1 김태경, "중소병원 간호사의 메치실린 내성 황색포도알균 감염관리의 지식과 수행정도" 보건의료산업학회 6 (6): 157-169, 2012

2 전민혁, "전국병원감염감시체계 중환자실 부문 결과: 2010년 7월부터 2011년 6월" 대한의료관련감염관리학회 17 (17): 28-39, 2012

3 정하윤, "요양병원 간호사의 병원감염관리에 대한 인지도와 수행도" 보건의료산업학회 7 (7): 131-141, 2013

4 "http://www.cdc.gov/hicpac/2007IP/2007isolation Precautions.html"

5 "http://www.cdc.go.kr/CDC/info/CdcKrInfo0301 .jsp?menuIds=HOME001-MNU1132-MNU1138-MN U0037-MNU1380&cid=12713"

6 Y. J. Park., "Survey on the Infection Control of Multidrug-Resistant Microorganisms in General Hospitals in Korea" 12 (12): 112-121, 2007

7 C. O'Boyle., "Staffing Requirements for Infection Control Programs in US Health Care Facilities : Delphi project" 30 (30): 321-333, 2002

8 L. J. Strausbaugh., "Preventing Transmission of Multidrug-resistant Bacteria in Health Care Settings : A Tale of 2 Guidelines" 15 (15): 828-835, 2006

9 C. D. Salgado., "Outcomes Associated with Vancomycin-Resistant Enterococci : A Meta-Analysis" 24 (24): 690-698, 2003

10 오향순, "National survey of the status of infection surveillance and control programs in acute care hospitals with more than 300 beds in the Republic of Korea" Mosby Inc. 34 (34): 223-233, 2006

11 J. D. Siegel., "Management of Multidrug-resistant Organisms in Health Care Settings, 2006" 35 (35): S165-S193, 2007

12 M. F. Kluytmans-Vandenbergh., "Dutch Guideline for Preventing Nosocomial Transmission of highly resistant Microorganisms(HRMO)" 33 (33): 309-313, 2005

13 I. M. Gould., "Costs of Healthcare-associated Methicillin-resistant Staphylococcus aureus and It‘s Control" 16 (16): 1721-1728, 2010

14 M. J. Neidell., "Costs of Healthcare-and Community-associated Infections with Antimicrobial-resistant versus Antimicrobial-susceptible Organisms" 55 (55): 807-815, 2012

15 C. A. DiazGranados., "Comparison of Mortality Associated with Vancomycin-resistant and Vancomycin-susceptible Enterococcal Bloodstream Infections : A Meta-Analysis" 41 (41): 327-333, 2005

16 C. E. Herr., "Additional Costs for Preventing the Spread of Methicillin-resistant Staphylococcus aureus and a Strategy for Reducing these Costs on a Surgical Ward" 24 (24): 673-678, 2003

17 H. S. Oh., "Activation of Infection Prevention and Control Program in Hospital via Healthcare Accreditation System. Final report" 1 : 1-72, 2011